Last Updated: 28 Jul 2025
Source: Statifacts
The global catheters market size was calculated at USD 37.6 billion in 2024 and is predicted to attain around USD 75.01 billion by 2034, expanding at a CAGR of 7.15% from 2025 to 2034. The market is growing owing to the rising consideration of catheters by individuals. These tubes are paving the way to making surgeries easier, comfortable, and, most importantly, safer for the patients as well as healthcare providers.
| Reports Attributes | Statistics |
| Market Size in 2024 | USD 37.6 Billion |
| Market Size in 2025 | USD 40.29 Billion |
| Market Size in 2032 | USD 65.33 Billion |
| Market Size by 2034 | USD 75.01 Billion |
| CAGR 2025 to 2034 | 7.15% |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
The catheters market deals with the production and distribution of catheters, thin, flexible, or inflexible hollow tubes made of clinical-grade material that have numerous applications including draining fluids from body cavities and inflation of body passages during surgical procedures. Some of the major types of catheters are urinary catheters, intravenous (IV) catheters, and cardiac catheters. Catheters are also utilized in several procedures, like gastrointestinal, neurovascular, and ophthalmic interventions, and for draining other body cavities or examining certain tissues.
The catheters market has benefited from AI exceedingly. AI is used to model new catheter shapes at a quicker pace using methods like neural operators in comparison with conventional methods. This results in the avoidance of infections without involving any antibiotics. To guide catheter navigation in simulated medical environments, AI, specifically inverse reinforcement learning (IRL), is being studied so that learning of complicated tasks will become faster and more effective. AI-driven systems can develop 3D maps and simplify navigation, supporting electrophysiologists in delivering more operative and competent procedures. AI algorithms can scrutinize enormous amounts of patient data, including clinical and imaging data, to improve predictions and medical decision-making in catheterization laboratories. Thus, personalized medicine can be curated.
The catheters market is growing as a consequence of demand for minimally invasive procedures and particular treatments. Marginally invasive procedures involve smaller incisions when supported by catheters. Due to this, the pain and tissue damage decrease, and patients can recover quickly. This, in turn, reduces the time spent by patients in hospitals and cost savings. There are various types of minimally invasive procedures, including cardiology (angioplasty, ablation), urology, neurology, and general surgery. Also, advances in catheter design, materials, and coatings, including smaller and smarter catheters, are proving to be safer during surgeries.
The catheters are useful for several treatments. For diagnosing and treating heart rhythm disorders through electrophysiology studies, they are extremely helpful. For carrying out procedures like angioplasty, stenting, and ablation, and for the diagnosis and treatment of heart rhythm disorders through electrophysiology studies, doctors are increasingly using catheters. Apart from cardiology, neurovascular conditions need catheters for treating strokes, aneurysms, and others. To lessen risks like thrombosis, catheters with silver ion coatings are gaining attention and driving the demand for the market.
The market faces some challenges, and the danger of widespread infections is one of them. The frequent use of catheters can lead to Catheter-Associated Infections (CAUTIs and CRBSIs) and cause serious damage to health. There is even a possibility of death. This major risk suppresses far-reaching and prolonged catheter use. As the number of infections might increase, stringent guidelines will slow down the growing usage of catheters. The healthcare professionals thus need to pay attention to strict sterilization and maintenance procedures, as just a minor misconduct can raise questions.
There is availability of other types of treatments for medical conditions that may limit the use of catheters. For some cardiovascular conditions, minimally invasive procedures and other treatment options are becoming usual. For dealing with urinary incontinence, alternatives like prompt toileting, urinals, bedside commodes, and incontinence garments are being asked for highly by the people. There are some advanced catheters that may cost a lot, especially for those with limited access to healthcare and insurance coverage. Also, the catheters increase the use of plastic to a higher level due to their disposable nature, which plummets the market growth.
The catheters market offers several opportunities. Due to the presence of keyhole surgery, which makes use of catheters for different purposes, recovery times for patients and expenditure are reduced. The novel materials like antimicrobial coatings, hydrophilic coatings, and bioabsorbable materials are improving the safety and capability of catheters while increasing comfort on the end of patients. The patients are hence looking forward to having treatment done using these catheters. Additionally, investments in healthcare keep thriving, giving rise to more use of catheters in hospitals and more access to the technology for individuals. This will result in more adoption of these devices in the future.
Talking about offering medical equipment extensively, White said, “When we began our partnership with Arlington, we knew we had an opportunity to accelerate our growth and expand our offerings to best serve our clients. Duke adds complementary capabilities and greater capacity to our already robust portfolio of full-service medical device manufacturing solutions, and will enable us to provide a greater breadth of complete solutions for our customer partners, who are doing critical, lifesaving work across the healthcare field.”
The peripheral intravenous catheters segment is dominating the catheters market. Peripheral intravenous catheters enable the supply of medications, including antibiotics, pain relievers, and other drugs, straight into the bloodstream. PIVCs can be used to manage blood or blood products to patients who have been subjected to blood loss or have low blood counts. PIVCs can be used to draw blood samples for laboratory testing, excluding the necessity for repeated needle punctures. They are feasible for patients who need intravenous treatment for a limited duration, like those in emergency rooms or during minor surgical procedures. They prove to be helpful in directing intravenous fluids and electrolytes to patients who are dehydrated, unable to take fluids orally, or similar.
The central venous catheters segment is the fastest growing one in the market. These catheters can stay in the same place for a long time, varying from weeks to months. A few types, like tunneled catheters and implanted ports, are created for long-standing accessibility. Due to this property of CVCs, they benefit the patients who need repetitive IV treatments. The central venous catheters generally enter a deep vein that’s not close to the surface of a patient’s skin and within your chest, neck, arm, or groin. A wide array of medications, including chemotherapy, antibiotics, and pain relievers, are carried by them along with intravenous fluids, blood transfusions, and parenteral nutrition. CVCs can help with hemodialysis and plasmapheresis as well.
The cardiovascular segment is dominating the market. Percutaneous (through the skin), catheter-based procedures for various structural heart conditions have been increasing lately. These procedures are mostly carried out in cardiac catheterization laboratories, and they prove to be an excellent alternative to open-heart surgery for several patients. Imaging technologies, similar to echocardiography, have resulted in the improvement of the precision of these procedures. Also, novel technologies, such as drug-eluting stents, bioresorbable scaffolds, and improved catheter materials, have broadened the possibility of catheter-based interventions. This is why cardiovascular catheters are being chosen more.
The urology segment is the fastest-growing one in the market. The Urological Conditions are on the rise worldwide. The urinary tract infections (UTIs) are among the most unexceptional bacterial infections. Due to changes in age and lifestyle, bladder cancer cases are increasing. Also, medical conditions like Benign Prostatic Hyperplasia (BPH), which occurs ordinarily in elderly men, and chronic kidney disease (CKD), which requires dialysis, need medical devices. All of these urinary conditions necessitate the use of catheters. In addition, Biodegradable catheters and Silicone catheters are known for their sustainability and biocompatibility. This is why their use in the field of urology is rising.
The hospital stores segment is dominating the catheters market. For diseases or conditions that require expertise, the hospitals are the first place to look. The more patients are admitted to these places, the more the demand for catheters can be expected. And the hospitals are the major locations where the medical devices are available and purchased in huge numbers. Hence, the access to catheters increases. Hospitals opt for more specialized catheter products to deal with the requirements of patients, ultimately leading to the growth of hospital stores.
The retail stores segment is the fastest-growing one in the market. Due to the accessibility of retail stores like pharmacies, purchasing catheters and other medical supplies has become much easier. There are a variety of options available for catheters to select from in these stores. Thus, patients with different diseases can buy catheters of several types depending on their needs. For the patients preferring to be treated at home, the stores prove to be helpful, and their accessibility to catheters increases. Also, the patients who can't afford the hospital expenses can make use of catheters at home after getting them from a store nearby or on an online platform.
The hospitals segment is dominating the catheters market. People give preference to hospitals when it comes to complex surgeries and treatments that require catheters. Hospitals offer all-encompassing care once the operation is done. They are trained to handle critical situations that require the use of catheters for many reasons, such as urinary drainage, medication delivery, and vascular access. Quite a lot of patients are diagnosed with conditions like end-stage renal disease, neurological disorders, which need catheter-based therapies at hospitals. There are trained medical professionals available on the premises, and so are the medical devices needed for catheter-related procedures, which calls for more demand for catheters.
The global catheters market is experiencing significant growth, with North America maintaining its position as the dominant region while Europe emerges as the fastest-growing market. The market of the Asia Pacific region is following both the regions mentioned earlier.
North America
The market in North America is growing with prevalence. The patients with diabetes or oncology or both need midline catheters for treatments like chemotherapy, hydration, or parenteral nutrition. The elderly need urinary catheters more than any other age group, since after undergoing a surgery, urinary incontinence exists. People are giving more preference to minimally invasive procedures and thus opting for catheters. The companies in the region are favorably investing in health-related medical devices.
BD (Becton, Dickinson and Company) proclaimed additional investments in its U.S. manufacturing network to add capacity for critical medical devices, including syringes, needles, and IV catheters. This needs to be done to foster the nation's health care system.
Europe
The market in the European region is growing rapidly. Patients in the region are shifting to home care, which is escalating the use of external and intermittent catheters that are fit for domestic use. People are becoming more aware of the benefits that catheters have. Using them properly has therefore become manageable. The healthcare infrastructure here is strong. The government is also taking initiatives to support the improvement in patient care and medical device accessibility. The firms are obtaining certifications so that specific devices can be used in a safe and healthy manner.
Anaconda Biomed declared that it has received CE-mark certification, which confirms that the ANA5 device complies with the European Union’s (EU) health, safety, and environmental protection standards and allows its subsequent commercial viability across the EU.
Asia Pacific
The catheters market in Asia Pacific is growing steadily. The designs, materials, and techniques used are evolving to keep the catheters safer. The respiratory conditions like COPD and pneumonia are on the rise here, and they require airway and closed suction catheters. The use of specialized catheters in complex procedures like balloon valvuloplasty and atrial septostomy makes these medical devices important to have. The companies from other countries are introducing new technology in the Asia Pacific region.
The catheters market is highly competitive, with leading pharmaceutical companies such as Medtronic, Boston Scientific, Teleflex Incorporated, Johnson & Johnson, B. Braun, Coloplast, Abbott, Edwards Lifesciences, Hollister, Becton, Dickinson and Company, Stryker, and Cook Medical holding the highest market share. Emerging biotech firms also play a crucial role by fostering a dynamic and evolving competitive landscape. The market is dominated by several pharmaceutical companies renowned for their significant contributions to medical equipment research and treatment. Based on recent data, the top three leading companies are:
Medtronic is a medical company with scientific knowledge. Its chief activities include research, design, manufacturing, and sales of biomedical engineering products. The company provides products for the treatment of heart valve disorders, heart failure, diseases of the coronary artery, aortic, peripheral vascular, venous, renal, and neurological diseases, spine and musculoskeletal disorders, and more. It also offers biological solutions for the orthopedic and dental markets. It supplies its products to hospitals, third-party healthcare providers, clinics, institutions, etc., in Asia Pacific, Europe, the Americas, the Middle East, and Africa. The yearly revenue of Medtronic was accounted to be $33,537,000 in 2024.
Boston Scientific Corp is a medical technology company. It provides products in the fields of gynecology, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology, vascular surgery, and more. The company serves hospitals, clinics, outpatient facilities, and medical offices across the globe. It operates manufacturing facilities in the US, Ireland, Costa Rica, Brazil, Malaysia, and Puerto Rico. It retails products directly and likewise through a network of distributors and dealers in Europe, the Middle East, Africa, Asia Pacific, and the Americas. The yearly revenue of Boston Scientific was positioned at $16,747,000 in 2024.
Teleflex Incorporated, which is a medical device company, mainly creates, manufactures, and distributes single-use medical devices in critical care and surgical applications. The company’s key products include vascular access devices, interventional catheters, anesthesia equipment, and respiratory care products. It delivers its products to hospitals, healthcare providers, distributors, and original equipment manufacturers (OEMs). It operates production capacities in the Czech Republic, Malaysia, Mexico, and the US. The yearly revenue of Teleflex Incorporated stood at $3,047,324 in 2024.
Published by Kesiya Chacko
-Carboxylated-(PVC-COOH)-Market.jpg)
